Emerging Therapies for Relapsed/Refractory Multiple Myeloma

Provided by the University of Nebraska Medical Center, Center for Continuing Education in Joint Providership with PlatformQ Health Education, LLC.

This activity is supported by an education grant from AbbVie, Karyopharm Therapeutics Inc., and Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.

Scroll to the Bottom of this Information to Begin this Course

Release date: September 13, 2017

Valid through: March 13, 2018

Specialty: Hematology-Oncology, Oncology

Topic: Multiple Myeloma

Media: Internet

Estimated Time to Complete Activity: 60 minutes

Target Audience

This program is primarily intended for US-based hematologist-oncologists, oncologists, oncology nurses, internal medicine physicians, family medicine/primary care physicians, and other clinicians who care for patients with multiple myeloma.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Identify disease–related, patient-related, and cytogenetic factors that shape treatment decisions for the management of relapsed/refractory MM
  • Examine safety and efficacy data of emerging strategies for patients with MM who have received prior lines of therapies including proteasome inhibitors and immunomodulatory agents
  • Discuss the therapeutic implications of combination regimens involving emerging agents with currently available treatment option

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credits

All other healthcare professionals completing this course will be issued a statement of participation.

Faculty

Ravi Vij, MD, MBA

Professor Medicine, Division of Medical Oncology, Section of BMT and Leukemia
Washington University School of Medicine

David Dingli, MD, PhD

Professor of Medicine, Hematology
Mayo Clinic

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and PlatformQ Health Education. The University of Nebraska Medical Center, Center for Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Live Activity
The University of Nebraska Medical Center, Center for Continuing Education designates the live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.0 hour of credit for completing this program.

Disclosures of Conflicts of Interest

David Dingli, MD, PhD
  • Research Funding: Karyopharm Therapeutics
  • Consulting/Member of IRC: Millennium/Takeda
  • Consulting: Janssen; Alexion Pharmaceuticals
Raji Vij, MD, MBA
  • Research Grant: Amgen, Takeda
  • Advisory Board/Honoraria: Amgen; Takeda; Celgene; BMS; Janssen; Karyopharm Therapeutics; AbbVie; Jazz Pharmaceuticals
University of Nebraska Medical Center, Center for Continuing Education
  • Lois Colburn, Executive Director: Has nothing to disclose.
  • Brenda C. Ram, CMP, CHCP, Coordinator: Has nothing to disclose.
PlatformQ Health Education, LLC
  • Anne Roc, PhD, Medical Director: Has nothing to disclose.
  • Karen Greb-Murphy, Program Manager: Has nothing to disclose.

Instructions for Participation and Credit

There are no fees to participate in this activity. To participate in the activity, go to http://www.OMedLive.com/. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive CE credit, participants must receive a minimum score of 70% on the post-test.

Hardware and Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Disclosure of Unapproved/Off Label Use

(if applicable)

The University of Nebraska Medical Center, Center for Continuing Education requires the presenter(s) to inform the audience when off-label or unapproved uses of drugs or devices are being discussed. Devices or drugs that are still undergoing clinical trials will be identified as such and will not be portrayed as standard, accepted therapy.

Disclaimer

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material. The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the University of Nebraska Medical Center, Center for Continuing Education, OMedLive, PlatformQ Health or the program grantors. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Contact Information

Accreditation Support: Please contact the University of Nebraska Medical Center, Center for Continuing Education at conted@unmc.edu or call 402-559-4152.

Technical Support: For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com.